Commercial Opportunities - Partnerships & Collaborations
We are seeking partners for research collaborations and commercial development of Pysnova Neurotech's portfolio of proprietary biomarkers for Neuropsychiatric disorders, including Schizophrenia and Bipolar disorder.
Potential partners include:
- Diagnostics companies seeking new opportunities to develop clinical and/or research assays for our biomarkers;
- Pharmaceutical companies seeking new tools enhance the efficiency of clinical development of new Neuropsychiatric drugs or to identify patient sub-groups that will respond to marketed drugs.
Psynova Neurotech is also seeking opportunities to use its tools to re-profile marketed drugs for use in Neuropsychiatric indications.
We are also interested in hearing from organisations with proprietary tools for biomarker identification and also from organisations with the capability to undertake clinical studies on biomarkers.